Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Monoamine Hypothesis of Depression Revisited: Could It Mechanistically Novel Antidepressant Strategies?
Fiammetta Cosci, Guy Chouinard
Elsevier eBooks (2019), pp. 63-73
Closed Access | Times Cited: 19

Showing 19 citing articles:

Iatrogenic Factors in Psychopathology
Giovanni A. Fava, Chiara Rafanelli
Psychotherapy and Psychosomatics (2019) Vol. 88, Iss. 3, pp. 129-140
Open Access | Times Cited: 76
Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder
Dinyadarshini Johnson, Sivakumar Thurairajasingam, Vengadesh Letchumanan, et al.
Nutrients (2021) Vol. 13, Iss. 5, pp. 1728-1728
Open Access | Times Cited: 67
Exercise as an antidepressant: exploring its therapeutic potential
Dong-Joo Hwang, Jung‐Hoon Koo, Tae-Kyung Kim, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 35
Reactivity of Olanzapine and Tricyclic Antidepressants on the Protective Effects of Trolox on Lipid Peroxidation Evaluated Using Fluorescence Anisotropy, Electron Paramagnetic Resonance Spectrometry, and Thermal Analysis
Yusuke Horizumi, Reo Tanada, Yuya Kurosawa, et al.
ACS Chemical Neuroscience (2025)
Open Access | Times Cited: 1
May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance
Giovanni A. Fava
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 58
Inflammatory Process and Immune System in Major Depressive Disorder
Norma Angélica Labra Ruiz, S S Daniel, Norma Osnaya Brizuela, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 25, Iss. 1, pp. 46-53
Open Access | Times Cited: 55
The Role of MicroRNA and Microbiota in Depression and Anxiety
Júlia M. Rosa, Douglas Affonso Formolo, Jiasui Yu, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 29
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Giovanni A. Fava, Fiammetta Cosci
The Journal of Clinical Psychiatry (2019) Vol. 80, Iss. 6
Closed Access | Times Cited: 51
Salivary hormones in depression: the future in diagnosis and treatment
Stefan Harsanyi, Ida Kupcová, Mária Csöbönyeiová, et al.
Annals of General Psychiatry (2025) Vol. 24, Iss. 1
Open Access
Differential Impact of Extracts from Distinct Sceletium Tortuosum Ecotypes on Central Neurotransmitter Concentrations in C57bl/6 Mice
Catherine H. Kaschula, Anna‐Mart Engelbrecht, Nokwanda P. Makunga, et al.
(2025)
Closed Access
Chaperone Sigma1R and Antidepressant Effect
М. В. Воронин, Yulia V. Vakhitova, С. Б. Середенин
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7088-7088
Open Access | Times Cited: 30
Depression unveiled: Insights into etiology and animal models for behavioral assessment, exploring the multifactorial nature and treatment of depression
Sachin More, Mohammed Kaleem, Rohini Kharwade, et al.
Brain Research (2024) Vol. 1847, pp. 149313-149313
Closed Access | Times Cited: 3
Dual Molecules Targeting 5-HT6 and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation
Monika Marcinkowska, Barbara Mordyl, Agata Siwek, et al.
ACS Chemical Neuroscience (2023)
Open Access | Times Cited: 4
Use of Extracellular Monomeric Ubiquitin as a Therapeutic Option for Major Depressive Disorder
José Luis Maldonado-García, Lissette Haydee García-Mena, Danelia Mendieta-Cabrera, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 841-841
Open Access | Times Cited: 1
Tibetan mineral-herbal medicine Zuotai alleviates the depressive-like behaviors in chronic restraint-stressed mice while regulating stress hormone, inflammation and monoamine
Cen Li, Cuiying Niu, Hongtao Bi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Study of Neuroendocrine-Immune Interactions in Major Depression to Develop More Efficient Therapeutic Options
Lenin Pavón, Danelia Mendieta-Cabrera, Gilberto Pérez‐Sánchez, et al.
Integrated science (2024), pp. 147-178
Closed Access
Correlation of receptor density and mRNA expression patterns in the human cerebral cortex
Matej Murgaš, Paul Michenthaler, Reed Murray Bruce, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
Machine learning methods applied for the prediction of biological activities of triple reuptake inhibitors
Gustavo Henrique Marques Sousa, Renan Augusto Gomes, Eliseu Ortega de Oliveira, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10277-10286
Closed Access | Times Cited: 1
La epidemia de la depresión: cuando la ciencia no se revisa a sí misma
Alberto Monterde Fuertes
ArtefaCToS Revista de estudios sobre la ciencia y la tecnología (2022) Vol. 11, Iss. 2, pp. 5-28
Open Access
Um novo olhar para o tratamento do transtorno depressivo maior: uma revisão dos estudos clínicos realizados com cetamina e escetamina
Layza Kowalski, Eslen Delanogare, Tiago Bittencourt de Oliveira
VITTALLE - Revista de Ciências da Saúde (2021) Vol. 33, Iss. 3, pp. 134-154
Open Access
Page 1

Scroll to top